Terapio is a biopharmaceutical company developing therapeutics based on the RLIP76 protein. It can be used as a medical countermeasure for radiation exposure and chemical threats to civilian, military, and first responder populations. The protein works though the oxidative stress pathway and serves both as a prophylactic and post exposure treatment.